LeMaitre Vascular Inc (NASDAQ:LMAT) announced a quarterly dividend on Monday, February 10th, Wall Street Journal reports. Shareholders of record on Tuesday, March 3rd will be given a dividend of 0.095
BidaskClub lowered shares of LeMaitre Vascular (NASDAQ:LMAT) from a hold rating to a sell rating in a research note released on Tuesday morning, BidAskClub reports. Other equities analysts have also r
LabCorp's (LH) Covance Drug Development delivers organic growth despite foreign currency headwind.
LabCorp's (LH) Covance Drug Development delivers organic growth despite foreign currency headwind.
Q4 2019 LeMaitre Vascular Inc Earnings Call
Investors continue to be optimistic about Zimmer's (ZBH) potential on its strong segmental and international results for the fiscal fourth quarter.
Hologic's (HOLX) latest offerings are set to improve flexibility and efficiency of laboratories.
LeMaitre Vascular (NASDAQ:LMAT) updated its FY 2020 After-Hours earnings guidance on Thursday. The company provided EPS guidance of 0.90-0.98 for the period, compared to the Thomson Reuters consensus

95 Biggest Movers From Friday

12:00am, Monday, 10'th Feb 2020
There's been a notable change in appetite for LeMaitre Vascular, Inc. (NASDAQ:LMAT) shares in the week since its...
Barrington analyst Michael Petusky maintained a Buy rating on Lemaitre Vascular (LMAT) today and set a price target of $38.00. The company's shares closed
Barrington analyst Michael Petusky maintained a Buy rating on Lemaitre Vascular ( LMAT – Research Report ) today and set a price target of $38.00 . The company’s shares closed last Monday at $32.1
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE